Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renata Varnaitė

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Proteomics|June 23, 2016
Meet the neighbors: Mapping local protein interactomes by proximity-dependent labeling with BioIDRenata Varnaitė, Stuart A MacNeill
Emerging Infectious Diseases|June 22, 2022
Deaths from Tick-Borne Encephalitis, SwedenRenata Varnaitė, Sara Gredmark-Russ, Jonas Klingström
Journal of Immunology (Baltimore, Md. : 1950)|January 12, 2020
Magnitude and Functional Profile of the Human CD4<sup>+</sup> T Cell Response throughout Primary Immunization with Tick-Borne Encephalitis Virus VaccineRenata Varnaitė, Kim Blom, Margit H Lampen, et al.
Plos Neglected Tropical Diseases|February 9, 2023
Safety and immunogenicity following co-administration of Yellow fever vaccine with Tick-borne encephalitis or Japanese encephalitis vaccines: Results from an open label, non-randomized clinical trialJohn Tyler Sandberg, Marie Löfling, Renata Varnaitė, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 29, 2021
Activation and Kinetics of Circulating T Follicular Helper Cells, Specific Plasmablast Response, and Development of Neutralizing Antibodies following Yellow Fever Virus VaccinationJohn Tyler Sandberg, Sebastian Ols, Marie Löfling, et al.
Immunity|July 25, 2023
Graded expression of the chemokine receptor CX3CR1 marks differentiation states of human and murine T cells and enables cross-species interpretationAnthonie Johan Zwijnenburg, Jyoti Pokharel, Renata Varnaitė, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 4, 2020
Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 PatientsRenata Varnaitė, Marina García, Hedvig Glans, et al.
Immunohorizons|April 26, 2019
Breadth and Dynamics of HLA-A2- and HLA-B7-Restricted CD8<sup>+</sup> T Cell Responses against Nonstructural Viral Proteins in Acute Human Tick-Borne Encephalitis Virus InfectionMargit H Lampen, Hannes Uchtenhagen, Kim Blom, et al.
Clinical & Translational Immunology|December 21, 2020
Innate lymphoid cell composition associates with COVID-19 disease severityMarina García, Efthymia Kokkinou, Anna Carrasco García, et al.
Clinical & Translational Immunology|July 14, 2021
SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisationJohn Tyler Sandberg, Renata Varnaitė, Wanda Christ, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Proteomics|June 23, 2016
Meet the neighbors: Mapping local protein interactomes by proximity-dependent labeling with BioIDRenata Varnaitė, Stuart A MacNeill
Emerging Infectious Diseases|June 22, 2022
Deaths from Tick-Borne Encephalitis, SwedenRenata Varnaitė, Sara Gredmark-Russ, Jonas Klingström
Journal of Immunology (Baltimore, Md. : 1950)|January 12, 2020
Magnitude and Functional Profile of the Human CD4<sup>+</sup> T Cell Response throughout Primary Immunization with Tick-Borne Encephalitis Virus VaccineRenata Varnaitė, Kim Blom, Margit H Lampen, et al.
Plos Neglected Tropical Diseases|February 9, 2023
Safety and immunogenicity following co-administration of Yellow fever vaccine with Tick-borne encephalitis or Japanese encephalitis vaccines: Results from an open label, non-randomized clinical trialJohn Tyler Sandberg, Marie Löfling, Renata Varnaitė, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 29, 2021
Activation and Kinetics of Circulating T Follicular Helper Cells, Specific Plasmablast Response, and Development of Neutralizing Antibodies following Yellow Fever Virus VaccinationJohn Tyler Sandberg, Sebastian Ols, Marie Löfling, et al.
Immunity|July 25, 2023
Graded expression of the chemokine receptor CX3CR1 marks differentiation states of human and murine T cells and enables cross-species interpretationAnthonie Johan Zwijnenburg, Jyoti Pokharel, Renata Varnaitė, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 4, 2020
Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 PatientsRenata Varnaitė, Marina García, Hedvig Glans, et al.
Immunohorizons|April 26, 2019
Breadth and Dynamics of HLA-A2- and HLA-B7-Restricted CD8<sup>+</sup> T Cell Responses against Nonstructural Viral Proteins in Acute Human Tick-Borne Encephalitis Virus InfectionMargit H Lampen, Hannes Uchtenhagen, Kim Blom, et al.
Clinical & Translational Immunology|December 21, 2020
Innate lymphoid cell composition associates with COVID-19 disease severityMarina García, Efthymia Kokkinou, Anna Carrasco García, et al.
Clinical & Translational Immunology|July 14, 2021
SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisationJohn Tyler Sandberg, Renata Varnaitė, Wanda Christ, et al.
Pageof 1